Scott Marsh Financial’s Thermo Fisher Scientific TMO Stock Holding History

Scott Marsh Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.76M	Buy	+4,330	New	+$1.81M	0.65%	35

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Scott Marsh Financial's TMO Position: Q2 2025 in Review

Scott Marsh Financial opened a new position in Thermo Fisher Scientific (TMO) in Q2 2025: 4,330 shares worth $1.76M. The stake represents 0.65% of the portfolio and ranks #35 among its holdings.

2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Scott Marsh Financial held 4,330 shares of Thermo Fisher Scientific worth $1.76M as of Q2 2025.
Thermo Fisher Scientific was a new Scott Marsh Financial position in Q2 2025.
Thermo Fisher Scientific made up 0.65% of Scott Marsh Financial's portfolio in Q2 2025, its #35 holding.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Scott Marsh Financial's 13F filing for Q2 2025, filed 14 Aug 2025.